MTND1P36

Across TCGA pan-cancer cohorts, MTND1P36 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MTND1P36 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MTND1P36 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P36 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

OV, THCA, and LIHC are the cancer types where MTND1P36 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	All	0.463	0.576	.002	54	view →
THCA	OS	Tertile	All	0.852	0.976	.009	30	view →
LIHC	OS	Tertile	III,IV	0.295	0.749	.008	18	view →
UCEC	DFS	Tertile	IV	0.234	0.599	.035	18	view →
DLBC	DFS	Tertile	II,III,IV	0.444	0.849	.044	9	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
LUAD	OS	Tertile	III,IV	0.321	0.549	.047	9	view →
KIRC	DFS	Quartile	II,III,IV	0.664	0.489	.032	8	view →
STAD	DFS	Tertile	All	0.465	0.599	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MTND1P36–OV (DFS)

Open the OV breakdown →